MATURA - Highlights and News

MAximising Therapeutic Utility in Rheumatoid Arthritis

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition - Frontiers: Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition Frontiers
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature.com: Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue Nature.com
Clinical implications of synovial tissue phenotypes in rheumatoid arthritis - Frontiers: Clinical implications of synovial tissue phenotypes in rheumatoid arthritis Frontiers
Rheumatoid arthritis - The Lancet: Rheumatoid arthritis The Lancet
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK - The BMJ: Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK The BMJ
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature.com: Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Nature.com
Clinical Applications of Synovial Biopsy - Frontiers: Clinical Applications of Synovial Biopsy Frontiers
Are innovation and new technologies in precision medicine paving a new era in patients centric care? - Journal of Translational Medicine: Are innovation and new technologies in precision medicine paving a new era in patients centric care? Journal of Translational Medicine
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes - Nature.com: Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes Nature.com
Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges - Frontiers: Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges Frontiers
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis - Nature.com: Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis Nature.com
Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis - Frontiers: Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis Frontiers
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature.com: Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics Nature.com
Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes - Frontiers: Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes Frontiers
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy - Frontiers: Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy Frontiers

The MATURA consortium includes academic groups and industry partners working together to identify and test biomarkers
predictive of response to biological therapy in patients with rheumatoid arthritis

Highlights and News

Related